Home
2021/22 Media Kit
Continued Medical Education
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
National Advertising
Agenda
Directory
Join Today
Event Agenda
Video
Careers
Search
About
Advertise
Advisory Board
Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Onco'Zine
Advertisement #1
Home
2021/22 Media Kit
Continued Medical Education
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
National Advertising
Agenda
Directory
Join Today
Event Agenda
Video
Careers
Soft-Tissue Sarcomas Changes the Biology of Immune Cells Surrounding Tumors to Promote Tumor Growth
Editorial Team
-
June 22, 2022
Activating the Immune Response Enables Liver Cancer Patient’s Immune System to Kill Cancerous Cells
Statue of a Woman with Incurable Breast Cancer Unveiled in Front of the Norwegian Parliament
Preventive Care May Be Free, but Follow-Up Diagnostic Tests Can Bring Big Bills
Pioneering Novel Targeted Treatments in Lung Cancer
FEATURED
Alleviating Targeted Therapy Side Effects: Essential for Patient QOL and Best Outcomes
Kathleen Kiernan Harnden, MD
-
June 8, 2022
What can we do to Better Manage our Pharmaceutical Waste?
Frithjof Laubinger
-
June 6, 2022
An Rx for American Healthcare: More Physician Entrepreneurship
Steven J. Cyr, MD
-
June 1, 2022
Combating Financial Hurdles: Setting up Physicians for Short- and Long-term Financial Success
Charlie Nemes
-
May 18, 2022
Polypharmacy – How Cancer Patients Face Higher Risks of Drug Interactions
Leslie Orr
-
May 16, 2022
Bioimpedance Spectroscopy Better than Tape Measure for Preventing Breast Cancer-Related Lymphedema
Sheila Ridner, PhD, RN, FAAN
-
May 13, 2022
Cancer Moonshot Funding Should Focus on Prevention Not just Cure or Treatment
Insoo Park
-
May 12, 2022
Tackling the Complexities of Cancer Treatment: Data Can Drive Value-Based Care
James Talcott, MD
-
May 11, 2022
Advertisement
NEWS
Soft-Tissue Sarcomas Changes the Biology of Immune Cells Surrounding Tumors to Promote Tumor Growth
Editorial Team
-
June 22, 2022
Activating the Immune Response Enables Liver Cancer Patient’s Immune System to Kill Cancerous Cells
Editorial Team
-
June 21, 2022
Statue of a Woman with Incurable Breast Cancer Unveiled in Front of the Norwegian...
Editorial Team
-
June 20, 2022
Preventive Care May Be Free, but Follow-Up Diagnostic Tests Can Bring Big Bills
Michelle Andrews
-
June 14, 2022
Pioneering Novel Targeted Treatments in Lung Cancer
Editorial Team
-
June 10, 2022
Alleviating Targeted Therapy Side Effects: Essential for Patient QOL and Best Outcomes
Kathleen Kiernan Harnden, MD
-
June 8, 2022
Momentum Study: Oral Treatment Improves Care of Patients with Myelofibrosis
Peter Hofland, Ph.D
-
June 7, 2022
Panitumumab + mFOLFOX6 Significantly Improves OS in Patients with RAS wild-type mCRC
Peter Hofland, Ph.D
-
June 7, 2022
Omitting Radiotherapy after Breast Conserving Surgery in Low-Grade Luminal A Breast Cancer Patients
Editorial Team
-
June 7, 2022
Biomarkers Predict Better Immunotherapy Treatment Outcomes for Patients with Pancreatic Cancer
Danielle Garcia
-
June 6, 2022
Surgery Rather than Radiation Associated with Lower Stroke Risk in Head and Neck Cancer...
Editorial Team
-
June 6, 2022
Encouraging Results for Cabozantinib Mono- and Combination Therapy Across Different Tumor Types
Danielle Garcia
-
June 6, 2022
CONFERENCE COVERAGE
Momentum Study: Oral Treatment Improves Care of Patients with Myelofibrosis
Peter Hofland, Ph.D
-
June 7, 2022
Panitumumab + mFOLFOX6 Significantly Improves OS in Patients with RAS wild-type mCRC
Peter Hofland, Ph.D
-
June 7, 2022
Omitting Radiotherapy after Breast Conserving Surgery in Low-Grade Luminal A Breast Cancer Patients
Editorial Team
-
June 7, 2022
Biomarkers Predict Better Immunotherapy Treatment Outcomes for Patients with Pancreatic Cancer
Danielle Garcia
-
June 6, 2022
Surgery Rather than Radiation Associated with Lower Stroke Risk in Head and Neck Cancer...
Editorial Team
-
June 6, 2022
Encouraging Results for Cabozantinib Mono- and Combination Therapy Across Different Tumor Types
Danielle Garcia
-
June 6, 2022
Oral Targeted Therapy Significantly Increases Overall Response Rate in Pediatric Low-Grade Gliomas
Editorial Team
-
June 6, 2022
Novel ADC Doubles Progression-Free Survival in Metastatic Breast Cancer with Low HER2 Expression
Danielle Garcia
-
June 6, 2022
Promising Activity with Zanidatamab In First-line Setting Of HER2+ Breast + Gastroesophageal Cancer
Danielle Garcia
-
June 6, 2022
Novel Drug Combination Demonstrates Promising Results in Treating Pancreatic Neuroendocrine Tumors
Peter Hofland, Ph.D
-
June 6, 2022
Ribociclib + Letrozole Maintained an OS benefit for Postmenopausal Patients with HR+/HER2- mBC
Peter Hofland, Ph.D
-
June 6, 2022
Ongoing Studies with Belantamab Mafodotin in Patients with Relapsed/Refractory Multiple Myeloma
Editorial Team
-
June 6, 2022
Advertisement
EDITORIAL
An Rx for American Healthcare: More Physician Entrepreneurship
Steven J. Cyr, MD
-
June 1, 2022
Bioimpedance Spectroscopy Better than Tape Measure for Preventing Breast Cancer-Related Lymphedema
Sheila Ridner, PhD, RN, FAAN
-
May 13, 2022
Cancer Moonshot Funding Should Focus on Prevention Not just Cure or Treatment
Insoo Park
-
May 12, 2022
Tackling the Complexities of Cancer Treatment: Data Can Drive Value-Based Care
James Talcott, MD
-
May 11, 2022
Surgical Site Infections: A Preventable Roadblock to Optimal Cancer Care
Anthony J. Senagore
-
May 9, 2022
Posttraumatic Stress Disorder: Frequently Occurring but Often Overlooked in Cancer Patients
Allison J. Applebaum, Ph.D.
-
February 8, 2022
ERIC ROSENTHAL REPORTS
Remembering Emil “Jay” Freireich—the Man Who Made Vince DeVita a ‘Believer’
Eric T. Rosenthal
-
February 13, 2021
Why Were Top HHS Officials? Interviews Thwarted by Their Press Offices?
Eric T. Rosenthal
-
March 5, 2019
EXPERT INTERVIEWS
Coming of Age: Antibody-drug Conjugates, Highly Targeted Anti-cancer Agents
Editorial Team
-
June 24, 2021
ASCO 2021: Promising Data for the Treatment of non-Hodgkin’s Lymphoma
Editorial Team
-
June 11, 2021
Interview: The Development of Sermonix’ Lasofoxifene in Advanced or Metastatic Breast Cancer
Editorial Team
-
September 12, 2020
X